Member Info for jagakajay

Don't understand how is is so difficult to hold a meeting. Zoom, Teams etc etc, jeez, its not that hard...

Same thing just happened to me...not a happy bunny!

They know what’s coming :-)

RNS 8/1
Processing of small bulk sample at a third-party processing facility has validated the Company's process flowsheet and confirmed the production of a 20.7 grams per tonne gold concentrate

Possibly - although I note that the other longstop extension RNS (29/10) said the same, only to be further extended in the 30/12 RNS.
who knows....would be nice to get something either way :-(

after hours RNS.
" We are pleased to advise that we have kicked the can so hard that our shoes have now worn out, and we cannot afford to purchase any new ones. Not only that, all of our bic biros have now run out of ink so we have been unable to pen an rns"

And silence.....
Tumbleweed....
Anybody out there? if so please get your pen out and write and RNS. Two words will do...”deal done”

2 more days until the revised longstop date is up. Do we reckon this will get over the line this time, or will the can be kicked further down the road?

Rare to see someone being honest like that, kudos Chaebol

Hey Sam. Been a long time.... i wondered if you were still in after all the previous rto nonsense. I never sold out either (just wasn’t worth it) so happy to see where this goes now.

It’s been a long time coming and a painful hold, but looks like it’s our time to shine.

Last fincap note I can see was 23/12
Avacta (AVCT): Corp
CTA filed with UK regulator
Confirmation that a Clinical Trial Application (CTA) has been submitted to the UK regulator for a Phase 1, open label, dose-escalation and expansion study of its lead pre|CISIONTM prodrug, AVA6000, is a significant milestone for Avacta and in line with the company’s stated objective to file before year end. We expect first patients to be dosed in Q2 2021 with pharmacokinetic and safety data from the first cohort around four months later. A successful outcome from this study will lead to one or more additional pre|CISION prodrugs being taken into the clinic as quickly as possible, for which Avacta has already begun development. We reiterate our SOTP target price of 310p, which assumes a rNPV valuation for pre|CISION of c.55p. This element of value should rise substantially on positive data, given that its proprietary pre|CISION chemistry could be applied to a range of other chemotherapies in a chemotherapy market worth c.$56bn by 2024.

Yep, starting mcap of 92m. Ticker is abdx

25th My 2016, SP opened at 67.5p and reached 77p, closing at 64.75p.

Data is all there if you look....

Simple math: Buy Out Price / Share in Issue:

2,759,000,000.00 shares in issue

buy out price SP in p
1,000,000,000.00 36.245
2,000,000,000.00 72.490
3,000,000,000.00 108.735
4,000,000,000.00 144.980
5,000,000,000.00 181.225
6,000,000,000.00 217.470
7,000,000,000.00 253.715
8,000,000,000.00 289.960
9,000,000,000.00 326.205
10,000,000,000.00 362.450

We should also understand that the "machine" is only capable of processing 000's of test per day (per the TTG RNS yesterday). Given that Heathrow has daily footfall of 220,000 passengers give or take, so they would need one helluva lot of these machines at 20k a pop to get through all passengers...Just cant see it as viable solution in the long term, but what do I know...

Lets assume that the remaining 700m comes from a low ball offer for Glen's share of Zanaga....that would put our stake at £2.48 per share......if's, but's, maybes....One day Rodney, one day

Loving this bit - especially for all those who said the port wasn't related to the SEZ!

"The Pointe-Noire Special Economic Zone will be progressively built in three phases: the start-up phase, which will see the construction of a multifunctional wharf in the Autonomous Port"

Looks like our port is gonna be built chaps, and first!

The targeted plants to be grown was in the same 19th March RNS ...numbers may have changed a little due to the move to seeds, but it gives you the general idea...

Highlands plans to grow approximately 40,000 hemp plants per annum in a 33,000 sq ft greenhouse (a minimum of 3 harvests per year is anticipated). The land also includes the ability to grow hemp outside and Highlands has a target to plant 20 acres this year, equating to around 50,000 hemp plants, and rising to 100 acres in 2020 (250,000 hemp plants, one harvest per year). Operating at full capacity in 2020 could see the business harvest approximately 290,000 hemp plants in that year.

Highlands will target a yield of 12 grams of CBD per indoor plant and 30 grams of CBD per outdoor plant. Estimated wholesale prices are $3 per gram although the Board believes sales made direct to retail channels could be at a premium of over 5 times this.

If he was still CFO I’d be concerned, but he hasn’t been in that position since last year, and has only been a NED. Odd RNS, but nothing to be concerned about IMO.